SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
When fragments link: a bibliometric perspective on the development of fragment-based drug discovery
9 references·1 citing·49 second hop
When fragments link: a bibliometric perspective on the development of fragment-based drug discovery (2018)When fragments link: a bibliometric persp…The mobility of elite life scientists: Professional and personal determinants (2017)The mobility of elite life sc…The two faces of inventions: The relationship between recombination and impact in pharmaceutical biotechnology (2016)The two faces of inventions: …CitNetExplorer: A new software tool for analyzing and visualizing citation networks (2014)CitNetExplorer: A new softwar…Models for open innovation in the pharmaceutical industry (2013)Models for open innovation in…Translational research: the changing landscape of drug discovery (2012)Translational research: the c…The importance of new companies for drug discovery: origins of a decade of new drugs (2010)The importance of new compani…Software survey: VOSviewer, a computer program for bibliometric mapping (2009)Software survey: VOSviewer, a…Drug discovery: new models for industry–academic partnerships (2008)Drug discovery: new models fo…Toward a new economics of science (1994)Toward a new economics of sci…Collaborative university–industry R&D practices supporting the pharmaceutical innovation process: Insights from a bibliometric review (2022)Collaborative university–indu…Open Innovation: The New Imperative for Creating and Profiting from Technology (2003)Can the pharmaceutical industry reduce attrition rates? (2004)How to improve R&D productivity: the pharmaceutical industry's grand challenge (2010)The antecedents of open business models: an exploratory study of incumbent firms (2014)The Timing of Codevelopment Alliances in New Product Development Processes: Returns for Upstream and Downstream Partners (2014)The role of management support for the implementation of open innovation practices in firms (2020)The Structure of Scientific Revolutions (1963)The Evolution of Cooperation (1981)Endogenous Technological Change (1990)The economic benefits of publicly funded basic research: a critical review (2001)Fifty Years of Empirical Studies of Innovative Activity and Performance (2010)Three frames for innovation policy: R&D, systems of innovation and transformative change (2018)Lessons from 60 years of pharmaceutical innovation (2009)The productivity crisis in pharmaceutical R&D (2011)A bibliometric measure of translational science (2020)Characterizing interdisciplinarity in drug research: A translational science perspective (2021)Regional advantage: culture and competition in Silicon Valley and Route 128 (1994)The New Argonauts. Regional Advantage in a Global Economy (2009)The Role of Public-Sector Research in the Discovery of Drugs and Vaccines (2011)Orphan drug development: an economically viable strategy for biopharma R&D (2012)Asymmetric Growth and Institutions in an Interdependent World (2017)An index to quantify an individual's scientific research output (2005)Visualizing Bibliometric Networks (2014)INNOVATION IN THE PUBLIC SECTOR: A SYSTEMATIC REVIEW AND FUTURE RESEARCH AGENDA (2015)Some bibliometric procedures for analyzing and evaluating research fields (2017)Guidelines for Bibliometric‐Systematic Literature Reviews: 10 steps to combine analysis, synthesis and theory development (2024)The price of innovation: new estimates of drug development costs (2003)Drug discovery in pharmaceutical industry: productivity challenges and trends (2012)Changing R&D models in research-based pharmaceutical companies (2016)Exploring different approaches to improve the success of drug discovery and development projects: a review (2020)CiteSpace II: Detecting and visualizing emerging trends and transient patterns in scientific literature (2005)bibliometrix : An R-tool for comprehensive science mapping analysis (2017)How to conduct a bibliometric analysis: An overview and guidelines (2021)An Evolutionary Theory of Economic Change. (1983)Technological Discontinuities and Organizational Environments (1986)Architectural Innovation: The Reconfiguration of Existing Product Technologies and the Failure of Established Firms (1990)Exploring Uncharted Territory: Knowledge Search Processes in the Origination of Outlier Innovation (2019)Technological Diversification to Green Domains: Technological Relatedness, Invention Impact and Knowledge Integration Capabilities (2021)The limits to open innovation and its impact on innovation performance (2022)Job Market Signaling (1973)Econometric Analysis of Cross Section and Panel Data (2001)The Increasing Dominance of Teams in Production of Knowledge (2007)Multiscale impact of researcher mobility (2018)Conceptualizing academic intellectual capital: definition and proposal of a measurement scale (2019)Data, measurement and empirical methods in the science of science (2023)Patterns in Strategy Formation (1978)Doing science together: Gaining momentum from long-term explorative university–industry research programs (2023)Bridging Academia and Enterprise: A Framework for Collaborative Success (2024)Study on the symbiosis evolution mechanism of the digital innovation ecosystem: considering government regulation (2024)
this work references cited by second hop

References

  • 2009Software survey: VOSviewer, a computer program for bibliometric mapping21,418 cited
  • 1994Toward a new economics of science2,479 cited
  • 2014CitNetExplorer: A new software tool for analyzing and visualizing citation networks699 cited
  • 2010The importance of new companies for drug discovery: origins of a decade of new drugs344 cited
  • 2013Models for open innovation in the pharmaceutical industry148 cited
  • 2008Drug discovery: new models for industry–academic partnerships140 cited
  • 2017The mobility of elite life scientists: Professional and personal determinants138 cited
  • 2016The two faces of inventions: The relationship between recombination and impact in pharmaceutical biotechnology87 cited
  • 2012Translational research: the changing landscape of drug discovery46 cited

Cited by

  • 2022Collaborative university–industry R&D practices supporting the pharmaceutical innovation process: Insights from a bibliometric review32 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work